Relationship Between ACE2 and Other Components of the Renin-Angiotensin System

被引：16
|
作者：
Cohen, Jordana B. [1 ,2 ]
Hanff, Thomas C. [2 ,3 ]
Bress, Adam P. [4 ]
South, Andrew M. [5 ,6 ,7 ,8 ]
机构：
[1] Univ Penn, Dept Med, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Perelman Sch Med, Div Cardiol, Philadelphia, PA 19104 USA
[4] Univ Utah, Dept Populat Hlth Sci, Div Hlth Syst Innovat & Res, Salt Lake City, UT USA
[5] Wake Forest Sch Med, Dept Pediat, Sect Nephrol, Winston Salem, NC 27101 USA
[6] Brenner Childrens Hosp, Winston Salem, NC USA
[7] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC 27101 USA
[8] Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Winston Salem, NC 27101 USA
来源：
CURRENT HYPERTENSION REPORTS | 2020年 / 22卷 / 07期
关键词：
COVID-19; Angiotensin-converting enzyme; Renin-angiotensin system; Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; Hypertension; Coronavirus infections; Chronic kidney disease; Cardiovascular disease; CONVERTING ENZYME-2 ACE2; CLINICAL CHARACTERISTICS; INHIBITION; EXPRESSION; BLOCKADE; FIBROSIS; INJURY; AXIS;
D O I：
10.1007/s11906-020-01048-y
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Purpose of the Review Angiotensin-converting enzyme 2 (ACE2) is a key counter-regulatory component of the renin-angiotensin system. Here, we briefly review the mechanistic and target organ effects related to ACE2 activity, and the importance of ACE2 in SARS-CoV-2 infection. Recent Findings ACE2 converts angiotensin (Ang) II to Ang-(1-7), which directly opposes the vasoconstrictive, proinflammatory, and prothrombotic effects of Ang II. ACE2 also facilitates SARS-CoV-2 viral entry into host cells. Drugs that interact with the renin-angiotensin system may impact ACE2 expression and COVID-19 pathogenesis; however, the magnitude and direction of these effects are unknown at this time. High quality research is needed to improve our understanding of how agents that act on the renin-angiotensin system impact ACE2 and COVID-19-related disease outcomes.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] RELATIONSHIP BETWEEN CARDIAC AND PLASMA RENIN-ANGIOTENSIN
    DANSER, AHJ
    ADMIRAAL, PJJ
    SOEI, LK
    SAXENA, PR
    VERDOUW, PD
    SCHALEKAMP, MADH
    CIRCULATION, 1992, 86 (04) : 328 - 328
  • [42] ACE2-From the renin-angiotensin system to gut microbiota and malnutrition
    Perlot, Thomas
    Penninger, Josef M.
    MICROBES AND INFECTION, 2013, 15 (13) : 866 - 873
  • [43] Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients
    Fradin, S
    Goulet-Salmon, B
    Chantepie, M
    Grandhomme, F
    Morello, R
    Jauzac, P
    Reznik, Y
    DIABETES & METABOLISM, 2002, 28 (01) : 27 - 32
  • [44] Special issue: ACE inhibitors and the renin-angiotensin system - Preface
    Chester, A
    VASCULAR PHARMACOLOGY, 2005, 42 (03)
  • [45] COMPARISON OF ANGIOTENSIN ANTAGONISTS WITH OTHER INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
    BUMPUS, FM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (SEP): : 20 - 20
  • [46] Relationship Between Nighttime Blood Pressure, the Renin-angiotensin System, and Melatonin
    Dominguez-Rodriguez, Alberto
    Abreu-Gonzalez, Pedro
    REVISTA ESPANOLA DE CARDIOLOGIA, 2013, 66 (10): : 831 - 832
  • [47] Relationship between the renin-angiotensin system genes and diabetic nephropathy in the Chinese
    Wu, SH
    Xiang, KS
    Zheng, TS
    Sun, DQ
    Weng, Q
    Zhao, HH
    Li, J
    CHINESE MEDICAL JOURNAL, 2000, 113 (05) : 437 - 441
  • [48] RELATIONSHIP BETWEEN CATECHOLAMINE AND RENIN-ANGIOTENSIN SYSTEM IN SPONTANEOUSLY HYPERTENSIVE RATS
    KAJIWARA, N
    KOBAYASHI, Y
    HASHIDA, J
    UCHIYAMA, T
    KITA, T
    SATOH, M
    ONO, M
    IZEKI, Y
    TEI, T
    TERASHIMA, H
    MISHINA, N
    KUSHIRO, T
    HATANO, M
    JAPANESE HEART JOURNAL, 1976, 17 (03): : 410 - 411
  • [49] Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
    François Silhol
    Gabrielle Sarlon
    Jean-Claude Deharo
    Bernard Vaïsse
    Hypertension Research, 2020, 43 : 854 - 856
  • [50] Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial
    Rathkolb, Vincent
    Traugott, Marianna T.
    Heinzel, Andreas
    Poglitsch, Marko
    Aberle, Judith
    Eskandary, Farsad
    Abrahamowicz, Agnes
    Mueller, Martin
    Knollmueller, Petra
    Shoumariyeh, Tarik
    Stuflesser, Jasmin
    Seeber, Ivan
    Gibas, Georg
    Mayfurth, Hannah
    Tinhof, Viktoria
    Schmoelz, Lukas
    Zeitlinger, Markus
    Schoergenhofer, Christian
    Jilma, Bernd
    Genser, Bernd
    Hoepler, Wolfgang
    Omid, Sara
    Karolyi, Mario
    Wenisch, Christoph
    Oberbauer, Rainer
    Zoufaly, Alexander
    Hecking, Manfred
    Reindl-Schwaighofer, Roman
    ISCIENCE, 2023, 26 (11)
12345